Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.13
Bid: 0.12
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.02 (16.667%)
Open: 0.13
High: 0.13
Low: 0.13
Prev. Close: 0.13
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Investment - Low 6 Limited

14 Dec 2020 07:00

RNS Number : 4555I
Gunsynd PLC
14 December 2020
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

 New Investment - Low 6 Limited

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has invested £200,010 in Low 6 Limited ("Low6"), a UK-based, influencer-led, B2B pool betting platform for franchises around the world. Low6 offers a white-label pool betting platform for professional sports franchises.

This investment in Low6 was made on the following terms:

· subscription for 6,667 ordinary shares at a price of £30 per share for a total consideration of £200,010; and

· this investment is a part of a £1.5m funding round.

 

The board of Gunsynd believes there is significant demand for a sports betting product which is built and designed to match the excitement of watching sports and which is also engaging and simple to use. Low6 provides a white-labelled mobile platform to its partners which enables them to offer a pooled sports betting experience to their app users and allows users to bet with each other.

Under its B2B model, Low6 partners with a sports team/franchise, such as a UK football club. The model reduces customer acquisition costs and strengthens brand and customer loyalty, which enhances customer retention. Low6 can either embed its platform within its partners' apps or build the app for its partners. The board of Gunsynd believes the Low6 partnership model is also highly scalable.

Low6 has a number of significant partnerships including Yinzcam Inc. which has 90+ million installs of its mobile sports and events apps world-wide and currently serves 190+ professional teams, leagues, events and venues in the US, Canada, Spain and Australia.

Low6 has raised over £8 million to date and expects to raise additional funds through a pre-IPO funding round with a view to completing an IPO at some stage throughout 2021.

An entity in which Peter Ruse, a Director of Gunsynd, has an interest, has subscribed for 916 shares for consideration of £27,500 at a price of £30 per share as part of the same funding round.

Hamish Harris, Gunsynd Plc Director, commented: "Gunsynd is very pleased to participate in this capital raising into Low 6 Limited. The investment offers exposure to what we believe to be an exciting sector of pooled sports betting where Low6 participants can wager against each other rather than a bookmaker. We believe Low6 is unique in that it partners with the sports team/franchises on a B2B model, reducing player/user acquisition costs, strengthening brand and customer loyalty, thereby reducing marketing costs and enhancing player retention."

 

About Low6 Limited

Low6 Limited a next generation sports betting platform. Further information can be found at https://low6.co.uk

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

The Directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris / Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUASBRRWUUAAA
Date   Source Headline
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing
20th Apr 20072:15 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSInterim Results
21st Mar 20075:43 pmRNSHolding(s) in Company
20th Mar 20075:26 pmRNSHolding(s) in Company
15th Mar 20075:01 pmRNSHolding(s) in Company
31st Jan 20077:01 amRNSPipeline Update
8th Jan 20075:57 pmRNSDirector/PDMR Shareholding
13th Dec 200610:08 amRNSTotal Voting Rights
13th Dec 20067:01 amRNSBoard Changes
21st Nov 20067:01 amRNSAnnual Report & Notice of AGM
28th Sep 20067:02 amRNSPreliminary Results
1st Aug 20067:01 amRNSProduct Development Update
26th Jun 20067:01 amRNSCOO & Board Appointment
3rd Apr 20064:23 pmRNSHolding(s) in Company
23rd Mar 20068:12 amRNSSyntopix Admission to AIM
23rd Mar 20068:11 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.